RN7SL363P

Across TCGA pan-cancer cohorts, RN7SL363P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RN7SL363P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RN7SL363P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL363P expression acts as an unfavorable survival marker, although some lineages such as HNSC and MESO show a favorable association.

KIRC, HNSC, and THYM are the cancer types where RN7SL363P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	III,IV	0.275	0.508	.001	96	view →
HNSC	OS	Tertile	All	0.781	0.637	.006	93	view →
THYM	OS	Quartile	II,III,IV	0.726	1.000	<.001	73	view →
MESO	OS	Tertile	All	0.735	0.487	.009	54	view →
GBM	OS	Tertile	All	0.278	0.440	.003	45	view →
CESC	DFS	Quartile	II,III,IV	0.246	0.553	<.001	44	view →
LGG	DFS	Tertile	All	0.152	0.472	<.001	30	view →
READ	DFS	Median	IV	0.936	0.179	.010	27	view →
UCEC	OS	Median	All	0.495	0.777	.003	24	view →
PAAD	DFS	Tertile	III,IV	0.275	0.794	.008	15	view →
LUSC	DFS	Quartile	III,IV	0.395	0.720	.003	12	view →
OV	OS	Tertile	II,III,IV	0.264	0.362	.030	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RN7SL363P–KIRC (DFS)

Open the KIRC breakdown →